High blood pressure stage 1
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Understanding High Blood Pressure Stage 1: Implications and Risks
Definition and Guidelines for Stage 1 Hypertension
Stage 1 hypertension is defined by the 2017 American College of Cardiology/American Heart Association (ACC/AHA) guidelines as having a systolic blood pressure (BP) between 130-139 mm Hg or a diastolic BP between 80-89 mm Hg . This redefinition has significant implications for both clinical practice and patient outcomes.
Cardiovascular Risks Associated with Stage 1 Hypertension
Increased Cardiovascular Disease (CVD) Risk
Research consistently shows that individuals with stage 1 hypertension are at a higher risk for cardiovascular events. A meta-analysis found that stage 1 hypertension is associated with a 1.38 times higher risk of cardiovascular disease (CVD) events compared to normal BP. This includes increased risks for coronary heart disease, stroke, and CVD mortality. Another study highlighted that young and middle-aged adults with stage 1 hypertension have a significantly higher risk of CVD, with hazard ratios of 1.78 for CVD incidence and 2.50 for CVD mortality.
Impact on Young Adults
Young adults with stage 1 hypertension also face increased risks. The CARDIA study demonstrated that young adults with stage 1 hypertension have a 1.75 times higher risk of cardiovascular events compared to those with normal BP. This risk is further supported by findings from the Kailuan Study, which showed that young adults with stage 1 hypertension had a hazard ratio of 1.82 for CVD events.
Maternal and Neonatal Outcomes
Adverse Pregnancy Outcomes
Stage 1 hypertension during pregnancy is linked to several adverse outcomes. A systematic review and meta-analysis found that stage 1 hypertension increases the risk of preterm delivery, small for gestational age, low birth weight, and early-term delivery. Another study confirmed that women with stage 1 hypertension have higher risks of hypertensive disorders of pregnancy, neonatal intensive care unit admissions, preterm birth, and gestational diabetes.
Need for Revised Pregnancy Management
Given these risks, there is a growing consensus that the management of stage 1 hypertension in pregnant women needs to be revisited. Current guidelines do not adequately address the treatment strategies for this group, highlighting a gap in clinical practice.
Long-Term Cardiovascular Implications
Progression to Higher BP Levels
Long-term studies indicate that individuals with stage 1 hypertension are likely to experience an increase in BP over time, leading to higher cardiovascular risks. For instance, a study on Korean adults found that those whose BP increased from normal to stage 1 hypertension had a higher risk of CVD and ischemic stroke. Similarly, the Chinese Multi-provincial Cohort Study reported that 65% of participants with stage 1 hypertension progressed to higher BP levels, significantly increasing their cardiovascular risk.
Subclinical Systolic Dysfunction
Stage 1 hypertension is also associated with subclinical changes in heart function. The PREVER study found that individuals with stage 1 hypertension had lower global longitudinal strain (GLS), indicating impaired systolic function compared to those with prehypertension.
Conclusion
Stage 1 hypertension, as defined by the 2017 ACC/AHA guidelines, is a significant risk factor for both cardiovascular and maternal-neonatal outcomes. The evidence underscores the need for early detection and management to mitigate these risks. Further research is essential to develop targeted treatment strategies, especially for young adults and pregnant women, to improve long-term health outcomes.
Sources and full results
Most relevant research papers on this topic